Standout Papers
- Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial (2013)
- Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial (2012)
Immediate Impact
6 from Science/Nature 55 standout
Citing Papers
Renal Cell Carcinoma
2024 Standout
Mechanisms of long COVID and the path toward therapeutics
2024 Standout
Works of Е. Д. Белоусова being referenced
Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 study
2017
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
2013 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Е. Д. Белоусова | 1398 | 68 | 529 | 583 | 561 | 48 | 1.9k | |
| Noah Berkowitz | 883 | 170 | 433 | 461 | 373 | 40 | 1.7k | |
| J.C. Kingswood | 1882 | 41 | 696 | 701 | 885 | 53 | 2.6k | |
| Aristotelis Astrinidis | 1371 | 4 | 810 | 613 | 414 | 33 | 1.9k | |
| Karen Agricola | 912 | 148 | 516 | 388 | 190 | 19 | 1.5k | |
| Julian R. Sampson | 1092 | 13 | 904 | 429 | 346 | 26 | 1.9k | |
| Jean Elwing | 756 | 7 | 345 | 295 | 763 | 50 | 1.5k | |
| Angelo M. Taveira‐DaSilva | 1776 | 6 | 273 | 529 | 915 | 58 | 2.6k | |
| Magdalena Karbowniczek | 648 | 10 | 910 | 524 | 347 | 30 | 1.8k | |
| Dorota Domańska‐Pakieła | 1228 | 89 | 369 | 483 | 167 | 20 | 1.5k | |
| Jeffrey E. DeClue | 863 | 12 | 1564 | 521 | 376 | 43 | 2.9k |
All Works
Login with ORCID to disown or claim papers
Loading papers...